Development of replication-defective adenovirus serotype 5 containing the capsid and 3C protease coding regions of foot-and-mouth disease virus as a vaccine candidate

被引:127
作者
Mayr, GA [1 ]
Chinsangaram, J [1 ]
Grubman, MJ [1 ]
机构
[1] ARS, PIADC, USDA, NAA, Greenport, NY 11944 USA
关键词
D O I
10.1006/viro.1999.9940
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A recombinant replication-defective human adenovirus serotype 5 vector containing FMDV capsid, P1-2A, and viral 3C protease coding regions was constructed. Two viral clones were isolated, Ad5-P12X3CWT, containing the wild-type (WT) 3C protease that processes capsid polyprotein precursor into mature capsid proteins, and Ad5-P12X3CMUT, containing a point mutation in the protease coding region that inhibits processing. In 293 cells infected with either virus, synthesis of the FMDV capsid polyprotein precursor occurred, but processing of the polyprotein into structural proteins VP0, VP3, and VP1 occurred only in 3CWT virus-infected cells. Immunoprecipitation with monospecific and monoclonal antibodies indicates possible higher order structure formation in Ad5-P12X3CWT virus-infected cells. The viruses were used to elicit immune responses in mice inoculated intramuscularly (im). Only virus containing the 3CWT elicited a neutralizing antibody response. After boosting, this neutralizing antibody response increased. Swine inoculated im with Ad5-P12X3CWT virus developed a neutralizing antibody response and were either completely or partially protected from contract challenge with an animal directly inoculated with virulent FMDV. This adenovirus vector may be an efficient system for the delivery of FMDV cDNA into animals, leading to a high level of neutralizing antibody production and protection from FMDV challenge. (C) 1999 Academic Press.
引用
收藏
页码:496 / 506
页数:11
相关论文
共 50 条
[1]   ASSEMBLY OF FOOT-AND-MOUTH-DISEASE VIRUS EMPTY CAPSIDS SYNTHESIZED BY A VACCINIA VIRUS EXPRESSION SYSTEM [J].
ABRAMS, CC ;
KING, AMQ ;
BELSHAM, GJ .
JOURNAL OF GENERAL VIROLOGY, 1995, 76 :3089-3098
[2]  
Ahl R., 1983, Report of the Research Group of the European Commission for the Control of Foot-and-Mouth Disease, Lelystad, 20-22 September 1983., P56
[3]   HIGH-LEVEL EUKARYOTIC INVIVO EXPRESSION OF BIOLOGICALLY-ACTIVE MEASLES-VIRUS HEMAGGLUTININ BY USING AN ADENOVIRUS TYPE-5 HELPER-FREE VECTOR SYSTEM [J].
ALKHATIB, G ;
BRIEDIS, DJ .
JOURNAL OF VIROLOGY, 1988, 62 (08) :2718-2727
[4]  
BACHRACH HL, 1975, J IMMUNOL, V115, P1636
[5]   DEVELOPMENTS IN FOOT-AND-MOUTH-DISEASE VACCINES [J].
BARTELING, SJ ;
VREESWIJK, J .
VACCINE, 1991, 9 (02) :75-88
[6]   ANALYSIS OF NEUTRALIZING ANTIGENIC SITES ON THE SURFACE OF TYPE-A12 FOOT-AND-MOUTH-DISEASE VIRUS [J].
BAXT, B ;
VAKHARIA, V ;
MOORE, DM ;
FRANKE, AJ ;
MORGAN, DO .
JOURNAL OF VIROLOGY, 1989, 63 (05) :2143-2151
[7]   SUBTYPING OF EUROPEAN FOOT-AND-MOUTH-DISEASE VIRUS-STRAINS BY NUCLEOTIDE-SEQUENCE DETERMINATION [J].
BECK, E ;
STROHMAIER, K .
JOURNAL OF VIROLOGY, 1987, 61 (05) :1621-1629
[8]   HOST-CELL SELECTION OF ANTIGENIC VARIANTS OF FOOT-AND-MOUTH-DISEASE VIRUS [J].
BOLWELL, C ;
BROWN, AL ;
BARNETT, PV ;
CAMPBELL, RO ;
CLARKE, BE ;
PARRY, NR ;
OULDRIDGE, EJ ;
BROWN, F ;
ROWLANDS, DJ .
JOURNAL OF GENERAL VIROLOGY, 1989, 70 :45-57
[9]   NEW APPROACHES TO VACCINATION AGAINST FOOT-AND-MOUTH-DISEASE [J].
BROWN, F .
VACCINE, 1992, 10 (14) :1022-1026
[10]   COEXPRESSION OF THE SIMIAN IMMUNODEFICIENCY VIRUS ENV AND REV PROTEINS BY A RECOMBINANT HUMAN ADENOVIRUS HOST RANGE MUTANT [J].
CHENG, SM ;
LEE, SG ;
RONCHETTIBLUME, M ;
VIRK, KP ;
MIZUTANI, S ;
EICHBERG, JW ;
DAVIS, A ;
HUNG, PP ;
HIRSCH, VM ;
CHANOCK, RM ;
PURCELL, RH ;
JOHNSON, PR .
JOURNAL OF VIROLOGY, 1992, 66 (11) :6721-6727